BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Podcasting since 2020 • 299 episodes
BioCentury This Week
Latest Episodes
Ep. 289 - Replacing Animal Models. Plus: RFK Jr. & FDA
FDA’s plan to move away from animal toxicity testing could expedite INDs and cut costs for biopharma companies, while helping the U.S. maintain its position as a clinical research hub. On ...
•
Season 6
•
Episode 289
•
36:55
Ep. 288 - FDA and Tariffs Turmoil, and AACR Preview
Loss of leadership, cuts to staffing and a proposed reorganization at FDA have heightened biotech risk amid an already turbulent mac...
•
Season 6
•
Episode 288
•
26:34
Ep. 287 - The Bear is Back: Marks’ Ouster, Tariffs and a Tumbling XBI
Biotech indexes are tumbling after one of FDA’s last veteran leaders was pushed out by HHS Secretary RFK Jr. and the threat of tariffs weigh on a key biotech index. On the latest BioCentury This Week podcast, BioCentury’s editors discu...
•
Season 6
•
Episode 287
•
25:46
Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
European venture firm Sofinnova Partners is expanding the reach of its Biovelocita accelerator beyond Italy to stretch across the greater continent. On the latest BioCentury This Week podcast, BioCentury’s editors
•
Season 6
•
Episode 286
•
24:30
Ep. 285 - BIO's Trump 2.0 Plan. Plus: Autoimmune CAR Ts & Telix's Radiopharma Play
BIO is engaging with President Donald Trump to protect and improve FDA. It’s also hoping biopharmas can dodge tariffs and find paths to modify the Inflation Reduction Act and reinstate pediatric priority review vouchers. On the latest BioCentur...
•
Season 6
•
Episode 285
•
28:26
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
